Evidence map›Paper›PMID 28701267›Full record

ReviewJournal of chromatography. A2017

Development of capillary liquid chromatography: A personal perspective.

Milos V Novotny

Abstract readHistorical ArticleReview
In one paragraph

Review in Journal of chromatography. A, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Origins, Technological Advancement, and Applications of Peptidomics.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  4. Article
  5. Consecutive Sample Injection Analysis in Tube Radial Distribution Chromatography.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Milos V NovotnyDepartment of Chemistry, Indiana University, 800 E. Kirkwood Ave., Bloomington, IN 47405, USA. Electronic address: novotny@indiana.edu.

Funding

Microfluidic Devices for Cancer Screening by N-Glycan AnalysisR01GM106084 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI JACOBSON, STEPHEN C · 2014 to 2017
$1.2M
New Chromatographic Technologies for Resolving Carbohydrate IsomersR21GM118340 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI NOVOTNY, MILOS · 2015 to 2016
$581k
NIGMS NIH HHS R01 GM106084NIGMS NIH HHS R21 GM118340
6 · The paper itself

Abstract

This is a historical account on the development of capillary LC from its beginning to the present day. The first investigations into the viability of capillary LC date back to the late 1970s, a decade after the pioneering efforts in HPLC. The drastically reduced column dimensions were required to counter the slow solute diffusion in liquids. There were numerous instrumental difficulties with sample introduction and detection in the picoliter or even femtoliter volumes. High-efficiency separations were needed in the analysis of complex biological mixtures. Miniaturization brought distinct advantages in spectroscopic and electrochemical detection. Since the 1980s, column technologies underwent significant changes: (a) from glass-drawn microcapillaries to slurry-packed, small-diameter fused silica columns; and (b) in microcapillaries packed alternatively with sub-2-μm particles or monoliths. The viability of LC-MS combination has dramatically promoted the use of small-diameter capillaries. Through "omics technologies", capillary LC/tandem MS accounts for most applications in proteomics, glycomics and metabolomics.

Indexed as

Chromatography, LiquidHistory, 20th CenturyHistory, 21st CenturyMass SpectrometryMetabolomicsMicrochemistryMiniaturizationProteomicsSilicon DioxideSilicon DioxideCapillary LC/MSLC-LIFOpen tubular vs. packed capillaries

Identifiers

PMID28701267
PMCPMC5675780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.